Drug Injury
Smoking Drug Chantix® Linked to Depression, Suicidal Behavior
The anti-smoking drug Chantix® has been linked to depression, suicidal thoughts, and violent behavior in some users, according to the Food and Drug Administration (FDA) (1). Government scientists are currently investigating the matter after reports of mood disorders and erratic behavior in some users came to their attention earlier this year.
Chantix Update:According to researchers, hundreds of patients taking Chantix have reported serious accidents, vision problems, and heart trouble.
The FAA then prohibited its pilots from using Chantix because
of its possible dangers, which also include blurred vision, dizziness,
confusion, loss of consciousness, and a previously established link to suicidal
behavior (source).
Chantix is a prescription drug designed to help adults quit smoking. It comes in a white tablet (0.5mg) and a blue tablet (1mg) and is usually taken for 12 weeks at a time (2).
Chantix may be dangerous to some users. The FDA issued a report that stated, “A preliminary assessment reveals that many of the cases reflect new-onset of depressed mood, suicidal ideation, and changes in emotion within days to weeks of initiating Chantix treatment (1).” Some of the patients who have been adversely affected by Chantix had no history of psychiatric illness and had not quit smoking when they experienced suicidal thoughts.
Update 1/18/08: Chantix will carry more prominent warnings that patients should be monitored for unusual activity including agitation, depression and suicidal behavior. The new warnings will be featured prominently on the anti-smoking drug’s labeling.
Our lawyers are committed to helping people affected by Chantix get the legal help they need so that victims can get the compensation they deserve if Chantix use has adversely affected their lives. Call one of our Chantix lawyers today. We want to help.
Chantix® is a registered trademark of Pfizer, Inc. and is used here only to identify the product in question.
Sources:
- Early Communication About an Ongoing Safety Review Varenicline (marketed as Chantix) from the FDA. Accessed 11/30/07 via www.fda.gov.
- Patient Information Sheet—Varenicline (marketed as Chantix) from the FDA. Accessed 11/30/07 via www.fda.gov.
This law firm is not associated with, sponsored by, or affiliated with the Food and Drug Administration or Pfizer, Inc.
| Print This Page | Disclaimer | Site Map | Empowered by cj Advertising | Links | Blog
Main Office
208 NW Fourth Street
Evansville, IN 47708
812-426-7200
Fax: 812-426-7207
Owensboro, KY Office
313 Frederica
Owensboro, KY 42302
-
CNN Reveals
CNN investigative reporters revealed damning evidence against major insurance companies.
-
Chantix®
The anti-smoking drug Chantix® has been linked to depression.
-
Digitek
The Food and Drug Administration has issued a Class I recall of the drug Digitek.
-
Fosamax®
Fosamax® (alendronate), has been linked to osteonecrosis of the jaw (ONJ).
-
Heparin Recall
There has been an urgent nationwide recall of heparin units manufactured by Baxter Healthcare.
-
Medtronic Sprint Dangers
May break down and deliver unnecessary, painful, and life-threatening shocks
-
Mesothelioma
Mesothelioma is an extremely deadly cancer of the membrane that lines the internal organs.
-
MRI Dye (NSF)
A dye used in MRI and MRA scans has been linked to a rare fatal skin disease in some users.
-
Trasylol®
May increase the chance for death, serious kidney damage, congestive heart failure, and stroke.

